Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:2629-2635

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uemura, S.
Right arrow Articles by Cooke, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uemura, S.
Right arrow Articles by Cooke, J. P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*BIOTIN
Related Collections
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2000;102:2629.)
© 2000 American Heart Association, Inc.


Basic Science Reports

Rapid and Efficient Vascular Transport of Arginine Polymers Inhibits Myointimal Hyperplasia

Shiro Uemura, MD; C. Garrison Fathman, MD; Jonathan B. Rothbard, PhD; John P. Cooke, MD, PhD

From the Department of Medicine, Stanford University School of Medicine, Stanford, and CellGate Inc (J.B.R.), Sunnyvale, Calif.

Correspondence to John P. Cooke, MD, PhD, Associate Professor and Director, Section of Vascular Medicine, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5246. E-mail John.Cooke{at}Stanford.edu

Background—We recently discovered that short polymers of arginine efficiently translocate across the cytoplasmic membrane independent of the basic amino acid transporter. We evaluated the kinetics and biological effects of heptamers of L-arginine and D-arginine (L-R7 and D-R7, respectively) in vascular cells. We assessed the effects of these peptides on the NO synthesis pathway and vascular cell proliferation.

Methods and Results—Human umbilical vein endothelial cell and rabbit vascular segments were incubated in medium containing biotin-labeled L-R7 or D-R7. Both polymers rapidly translocated through the vessel wall and into the vascular cells in a dose- and time-dependent fashion. At a dose of 10 µmol/L for 30 minutes, 100% of the endothelial cells showed evidence of cytoplasmic and nuclear localization of the peptides. To evaluate the biological effects of the polymer translocation on myointimal formation, rabbit jugular vein segments were incubated with polymers (10 µmol/L, 30 minutes) or vehicle before arterial interposition grafting. Planimetric measurement 28 days after surgery revealed that L-R7 and D-R7 substantially reduced myointimal formation compared with the control condition (intima/media ratio: control 1.50.5, L-R7 0.40.2, and D-R7 0.80.2; P<0.05). Furthermore, basal nitrate and nitrite production from L-R7–treated grafts was significantly higher than that from both control and D-R7–treated veins. Studies in vitro of cultured vascular smooth muscle cells revealed that both polymers also exhibit an NO-independent inhibition of vascular smooth muscle cell proliferation.

Conclusions—Short polymers of arginine have the unique ability of vascular cell translocation, and they also have direct biological effects. These attributes are potentially useful in treating myointimal hyperplasia.


Key Words: amino acids • nitric oxide • muscle, smooth




This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
W.-W. Lin, Y.-C. Lin, T.-Y. Chang, S.-H. Tsai, H.-C. Ho, Y.-T. Chen, and V. C. Yang
Caveolin-1 Expression Is Associated with Plaque Formation in Hypercholesterolemic Rabbits
J. Histochem. Cytochem., August 1, 2006; 54(8): 897 - 904.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. S. Goligorsky
Endothelial cell dysfunction: can't live with it, how to live without it
Am J Physiol Renal Physiol, May 1, 2005; 288(5): F871 - F880.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. H. Kown, M. A. Lijkwan, C. L. Jahncke, S. Murata, J. B. Rothbard, and R. C. Robbins
L-arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1065 - 1070.
[Abstract] [Full Text] [PDF]